OMCL Omnicell, Inc.

33.18USD-4.27%Mkt Cap: 1.53B USDP/E: 34.56

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap1.53B USD
Enterprise Value1.48B USD
Revenue (TTM)1.24B USD
Gross Profit503.44M USD
Net Income (TTM)2.05M USD
Revenue/Share27.37 USD
Last Price33.18 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees3.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)34.56
P/E (Forward)16.52
PEG15.40
EV/EBITDA16.84
EV/Revenue1.19
P/S1.23
P/B1.16
EPS (TTM)0.96 USD
EPS (Forward)2.01 USD
52W Range
31.756% of range55.00
52W High55.00 USD
52W Low31.75 USD
Profitability
Gross Margin42.49%
Oper. Margin4.59%
EBITDA Margin7.07%
Profit Margin0.17%
ROE0.17%
ROA0.10%
ROIC0.21%
ROCE0.34%
Growth
Revenue Growth-0.90%
Earnings Growth100.10%
Cash Flow & Leverage
Operating CF127.30M USD
CapEx (TTM)57.93M USD
FCF Margin10.96%
FCF Yield8.93%
Net Debt-114.11M USD
Net Debt/EBITDA-1.30
Net Debt/FCF-0.84
Balance Sheet
Debt/Equity0.17
Current Ratio1.66
Quick Ratio1.20
Book Value/Sh28.64 USD
Cash/Share6.84 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)57.43 USD
Upside (mean)+73.1%
Target Range50.00 USD – 68.00 USD
50.00+73.1% to mean68.00
# Analysts7
Ownership
Shares Out.46.00M
Float44.76M
Insiders2.13%
Institutions106.99%
Short Interest
Short Ratio7.2d
Short % Float9.94%
Short % Out.8.20%
Shares Short3.77M
Short (prev mo.)3.64M
Technical
SMA 5035.08 (-5.4%)
SMA 20038.29 (-13.3%)
Beta0.89
S&P 52W Chg12.08%
Avg Vol (30d)549.07K
Avg Vol (10d)559.47K
Technical Indicators
RSI (14)38.3
MACD-0.4411
MACD Signal-0.0214
MACD Hist.-0.4198
BB Upper39.13 USD
BB Middle36.18 USD
BB Lower33.24 USD
BB Width16.28%
ATR (14)1.493 USD
Vol Ratio (20d)0.71x

About Omnicell (NASDAQ: OMCL)

›

Omnicell (NASDAQ: OMCL) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 3,450 employees.

The shares were at 33.18 USD on 19 November 2026, down 7.2% over 52 weeks. Its 52-week range is 31.75 USD to 55.00 USD: the price is 39.7% below the high and 4.5% above the low.

At a market capitalisation of 1.53B USD, it trades at 34.6 times trailing earnings and 16.5 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 18% for OMCL.

Omnicell reports return on equity of 0.2%, an operating margin of 4.6% and revenue down 0.9% year over year.

It holds more cash than debt, a net cash position of 114.11M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 7 analysts cover the stock; their mean price target of 57.43 USD is 73.1% above the current price. The next earnings report is expected on 4 February 2027.